Status:
COMPLETED
High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome
Lead Sponsor:
Groupe Hospitalier Pitie-Salpetriere
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Tourette's Syndrome
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
Tourette's syndrome is a disabling neuropsychiatric disorder with major psychosocial consequences in some patients. The pathophysiology is still unknown. Some data suggest an dysfunction of limbic cir...
Eligibility Criteria
Inclusion
- Tourette's syndrome (DSM IV)
- inducing a disability in the social and personal life
- No improvement with medical treatment
- Severe self suffering
Exclusion
- Cognitive impairment (MMS \< 24)
- Depression
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00139308
Last Update
August 31 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere
Paris, France, 75013